Hsie A W, San Sebastian J R, Perdue S W, Schenley R L, Waters M D
Health and Safety Research Division, Oak Ridge National Laboratory, TN 37831.
Mol Toxicol. 1987 Apr-Sep;1(2-3):217-34.
Previously, we have shown that Chinese hamster ovary (CHO) cells are useful for quantifying chemical-induced gene mutations. We have defined the conditions of a Multiplex CHO System which permits determination of mutagen-induced chromosome aberration, and sister chromatid exchange (SCE) in addition to cytotoxicity and gene mutation in the same treated culture. This allows us to extend the spectrum of quantitative mutagenesis to include clastogenic endpoints. In the present study, we used four carcinogenic/noncarcinogenic pairs to validate the relative utility and sensitivity of each endpoint, and to study the interrelationship of these four distinct biological effects. These compounds include the direct-acting carcinogens N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), ICR 170 and their noncarcinogenic analogue N-methyl-N'-nitroguanidine (MNG) and ICR 170-OH, and the procarcinogens benzo[a]pyrene (B[a]P) and dimethylnitrosamine (DMN) and their noncarcinogenic analogues pyrene and dimethylamine (DMA) respectively. A rat liver homogenate preparation (S9) was used to assay for the biological activities of procarcinogens. Under our experimental conditions, we observed that carcinogens DMN, B[a]P, MNNG and ICR 170, but not their noncarcinogenic counterparts, showed all four biological effects. Our studies with these chemicals showed that cytotoxicity does not necessarily correlate with any of the genetic endpoints. On a molar basis, noncarcinogens, pyrene and ICR 170-OH show similar toxicity to carcinogens B[a]P and ICR 170, respectively. The other two non-carcinogenic analogues, DMA and MNG, exhibit minimal toxicity at concentrations 10-1,000 times higher than cytotoxic concentrations of the corresponding carcinogens, DMN and MNNG. In general, gene mutation and SCE are more sensitive than chromosome aberration assay. The gene mutation assay is more specific than SCE and chromosome aberration assays since none of the noncarcinogens exhibit a detectable response in the gene mutational assay. ICR 170 and MNNG are much more active than B[a]P and DMN as ranked on a molar basis. These results indicate that the Multiplex CHO System is capable of discriminating divergent structural classes of carcinogenic and noncarcinogenic compounds, such as the eight chemicals chosen for our study.
此前,我们已经表明中国仓鼠卵巢(CHO)细胞可用于定量化学诱导的基因突变。我们定义了多重CHO系统的条件,该系统除了能测定同一处理培养物中的细胞毒性和基因突变外,还能测定诱变剂诱导的染色体畸变和姐妹染色单体交换(SCE)。这使我们能够将定量诱变的范围扩展到包括致断裂终点。在本研究中,我们使用了四对致癌/非致癌化合物来验证每个终点的相对效用和敏感性,并研究这四种不同生物学效应之间的相互关系。这些化合物包括直接作用的致癌物N-甲基-N'-硝基-N-亚硝基胍(MNNG)、ICR 170及其非致癌类似物N-甲基-N'-硝基胍(MNG)和ICR 170-OH,以及前致癌物苯并[a]芘(B[a]P)和二甲基亚硝胺(DMN)及其非致癌类似物芘和二甲胺(DMA)。使用大鼠肝脏匀浆制剂(S9)来测定前致癌物的生物学活性。在我们的实验条件下,我们观察到致癌物DMN、B[a]P、MNNG和ICR 170,但不是它们的非致癌对应物,表现出所有四种生物学效应。我们对这些化学物质的研究表明,细胞毒性不一定与任何遗传终点相关。以摩尔为基础,非致癌物芘和ICR 170-OH分别对致癌物B[a]P和ICR 170表现出相似的毒性。另外两种非致癌类似物,DMA和MNG,在浓度比相应致癌物DMN和MNNG的细胞毒性浓度高10 - 1000倍时表现出最小的毒性。一般来说,基因突变和SCE比染色体畸变检测更敏感。基因突变检测比SCE和染色体畸变检测更具特异性,因为在基因突变检测中没有一种非致癌物表现出可检测到的反应。以摩尔为基础排序时,ICR 170和MNNG比B[a]P和DMN活性高得多。这些结果表明多重CHO系统能够区分致癌和非致癌化合物的不同结构类别,例如我们研究中选择的八种化学物质。